HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Eric L Simpson Selected Research

Steroids

3/2015A systematic review of topical corticosteroid withdrawal ("steroid addiction") in patients with atopic dermatitis and other dermatoses.
7/2004Tacrolimus ointment: utilization patterns in children under age 2 years.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Eric L Simpson Research Topics

Disease

139Atopic Dermatitis (Atopic Eczema)
12/2024 - 09/2003
43Eczema
12/2024 - 09/2011
24Pruritus (Itching)
10/2023 - 01/2012
15Infections
12/2023 - 01/2008
14Conjunctivitis
11/2023 - 12/2016
10Inflammation (Inflammations)
01/2023 - 05/2008
9Asthma (Bronchial Asthma)
01/2023 - 01/2017
7Skin Diseases (Skin Disease)
01/2023 - 09/2003
7Injection Site Reaction
12/2022 - 12/2016
5Body Weight (Weight, Body)
05/2024 - 01/2020
5Dermatitis
01/2024 - 07/2005
5Pain (Aches)
10/2021 - 12/2018
4Acne Vulgaris
10/2022 - 07/2004
4Hypersensitivity (Allergy)
03/2020 - 06/2004
3Erythema
05/2024 - 11/2022
3Dysbiosis
11/2023 - 01/2018
3Food Hypersensitivity (Food Allergy)
01/2023 - 03/2006
3Kaposi Varicelliform Eruption (Eczema Herpeticum)
12/2022 - 06/2019
3Nasopharyngitis
01/2021 - 01/2016
3Psoriasis (Pustulosis Palmaris et Plantaris)
01/2020 - 01/2018
2Edema (Dropsy)
05/2024 - 09/2023
2Neoplasms (Cancer)
12/2023 - 05/2021
2Blepharitis
01/2023 - 01/2021
2Seasonal Allergic Rhinitis (Hay Fever)
01/2023 - 01/2017
2Opportunistic Infections (Opportunistic Infection)
12/2022 - 05/2021
2Respiratory Tract Infections (Respiratory Tract Infection)
12/2022 - 01/2021
2Herpes Zoster
09/2021 - 06/2019
2Nausea
01/2021 - 01/2019
2Headache (Headaches)
01/2021 - 01/2019
2Insulin Resistance
01/2020 - 01/2018
2Allergic Rhinitis
01/2020 - 01/2017
2Ichthyosis Vulgaris (Dominant Ichthyosis Vulgaris)
06/2016 - 07/2008
2Contact Dermatitis (Eczema, Contact)
08/2006 - 06/2004
2Allergic Contact Dermatitis
08/2006 - 07/2004
1Skin Neoplasms (Skin Cancer)
12/2023
1Staphylococcal Infections
10/2023
1Alopecia (Baldness)
01/2023
1Ectropion
01/2023
1Cardiac Arrhythmias (Arrythmia)
01/2023
1Virus Diseases (Viral Diseases)
01/2023
1Ichthyosis (Xeroderma)
01/2023
13 Atopic Dermatitis
01/2023
1Eosinophilia
01/2023

Drug/Important Bio-Agent (IBA)

43dupilumabIBA
05/2024 - 01/2016
19Immunoglobulin A (IgA)IBA
05/2024 - 02/2016
16Adrenal Cortex Hormones (Corticosteroids)IBA
11/2023 - 12/2008
16abrocitinibIBA
09/2023 - 01/2020
11Interleukin-13IBA
11/2023 - 01/2016
10CytokinesIBA
11/2023 - 01/2008
10Immunoglobulin E (IgE)IBA
10/2023 - 03/2006
9baricitinibIBA
12/2023 - 04/2019
8upadacitinibIBA
05/2024 - 01/2021
8Monoclonal AntibodiesIBA
12/2023 - 01/2016
8EmollientsIBA
01/2023 - 10/2010
8Janus Kinase 1IBA
01/2023 - 01/2020
7Janus KinasesIBA
12/2024 - 01/2021
7ruxolitinibIBA
12/2024 - 10/2021
7InterleukinsIBA
11/2023 - 01/2016
7Biomarkers (Surrogate Marker)IBA
10/2023 - 02/2014
6tralokinumabIBA
11/2023 - 11/2022
6Interleukin-4 (Interleukin 4)IBA
01/2023 - 01/2016
6Ointments (Pastes)IBA
11/2019 - 01/2008
5lebrikizumabIBA
05/2024 - 01/2018
5Janus Kinase InhibitorsIBA
01/2024 - 06/2019
5AllergensIBA
01/2023 - 06/2004
4Immunosuppressive Agents (Immunosuppressants)IBA
07/2023 - 07/2016
44-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA
10/2021 - 12/2018
4crisaboroleIBA
04/2021 - 09/2016
4Phosphodiesterase 4 InhibitorsIBA
07/2019 - 08/2012
4Filaggrin ProteinsIBA
10/2018 - 07/2008
3Interleukin-4 Receptors (Interleukin 4 Receptor)IBA
01/2023 - 12/2016
3AntigensIBA
01/2023 - 09/2011
3Anti-Bacterial Agents (Antibiotics)IBA
10/2022 - 10/2013
2Immunoglobulin G (IgG)IBA
10/2023 - 01/2008
2Janus Kinase 2IBA
07/2021 - 05/2021
2Lipoproteins (Lipoprotein)IBA
01/2020 - 01/2018
2Adalimumab (Humira)FDA Link
10/2019 - 01/2018
2Immunologic Factors (Immunomodulators)IBA
06/2019 - 08/2014
2VaccinesIBA
01/2019 - 09/2007
2apremilastIBA
01/2019 - 08/2012
2SteroidsIBA
03/2015 - 07/2004
2Antiviral Agents (Antivirals)IBA
02/2014 - 01/2008
2Anti-Inflammatory Agents (Anti-Inflammatories)IBA
03/2013 - 01/2012
2Calcineurin InhibitorsIBA
01/2012 - 03/2010
2Proteins (Proteins, Gene)FDA Link
01/2012 - 09/2011
2Tacrolimus (Prograf)FDA LinkGeneric
03/2010 - 12/2008
2efalizumab (Raptiva)FDA Link
10/2009 - 05/2008
2ChemokinesIBA
09/2008 - 01/2008
1Immunomodulating AgentsIBA
01/2024
1omega-Chloroacetophenone (Mace)IBA
12/2023
1Chemokine CCL17IBA
11/2023
1AmmoniaIBA
06/2023
1Environmental Pollutants (Pollutants, Environmental)IBA
01/2023
1nemolizumabIBA
01/2023
1IsocyanatesIBA
01/2023
1SmokeIBA
01/2023

Therapy/Procedure

39Therapeutics
01/2024 - 02/2007
4Skin Care
03/2020 - 09/2011
4Phototherapy (Light Therapy)
10/2019 - 08/2014
2Aftercare (After-Treatment)
01/2023 - 01/2016